Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

105 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Treatment of mixed cryoglobulinemia with recombinant interferon alpha and adjuvant therapies. A prospective study on 20 patients.
Cohen P, Nguyen QT, Dény P, Ferrière F, Roulot D, Lortholary O, Jarrousse B, Danon F, Barrier JH, Ceccaldi J, Constans J, Crickx B, Fiessinger JN, Hachulla E, Jaccard A, Seligmann M, Kazatchkine M, Laroche L, Subra JF, Turlure P, Guillevin L. Cohen P, et al. Among authors: ceccaldi j. Ann Med Interne (Paris). 1996;147(2):81-6. Ann Med Interne (Paris). 1996. PMID: 8760684 Clinical Trial.
[Mental health of HIV-positive women in France in the era of antiretroviral therapies: what differences between men and women? What is at stake?].
Préau M, Bouhnik AD, Heard I, Brunet-François C, LeMoing V, Collin F, Spire B; Groupe Anrs-Vespa; Groupe Aproco-Capilote (Anrs-Co-8). Préau M, et al. Med Sci (Paris). 2008 Mar;24 Spec No 2:151-60. doi: 10.1051/medsci/2008242s151. Med Sci (Paris). 2008. PMID: 18681132 Free article. French. No abstract available.
Boosted lopinavir- versus boosted atazanavir-containing regimens and immunologic, virologic, and clinical outcomes: a prospective study of HIV-infected individuals in high-income countries.
HIV-CAUSAL Collaboration; Cain LE, Phillips A, Olson A, Sabin C, Jose S, Justice A, Tate J, Logan R, Robins JM, Sterne JA, van Sighem A, Reiss P, Young J, Fehr J, Touloumi G, Paparizos V, Esteve A, Casabona J, Monge S, Moreno S, Seng R, Meyer L, Pérez-Hoyos S, Muga R, Dabis F, Vandenhende MA, Abgrall S, Costagliola D, Hernán MA. HIV-CAUSAL Collaboration, et al. Clin Infect Dis. 2015 Apr 15;60(8):1262-8. doi: 10.1093/cid/ciu1167. Epub 2015 Jan 6. Clin Infect Dis. 2015. PMID: 25567330 Free PMC article.
Uncontrolled viral replication as a risk factor for non-AIDS severe clinical events in HIV-infected patients on long-term antiretroviral therapy: APROCO/COPILOTE (ANRS CO8) cohort study.
Ferry T, Raffi F, Collin-Filleul F, Dupon M, Dellamonica P, Waldner A, Strady C, Chêne G, Leport C, Moing VL; ANRS CO8 (APROCO-COPILOTE) Study Group. Ferry T, et al. J Acquir Immune Defic Syndr. 2009 Aug 1;51(4):407-15. doi: 10.1097/QAI.0b013e3181acb65f. J Acquir Immune Defic Syndr. 2009. PMID: 19474755
Prognostic factors of combined viral load and CD4+ cell count responses under triple antiretroviral therapy, Aquitaine cohort, 1996-1998.
Marimoutou C, Chêne G, Mercié P, Neau D, Farbos S, Morlat P, Ceccaldi J, Dabis F; Groupe d'Epidemiologie Clinique du SIDA en Aquitaine. Marimoutou C, et al. Among authors: ceccaldi j. J Acquir Immune Defic Syndr. 2001 Jun 1;27(2):161-7. doi: 10.1097/00126334-200106010-00011. J Acquir Immune Defic Syndr. 2001. PMID: 11404538 Clinical Trial.
105 results